Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elliott Vichinsky

Showing results (91-100 of 132) with videos related to

Pageof 14
Sort By:
Transfusion|July 30, 2013
Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME)Elliott Vichinsky, Lynne Neumayr, Sean Trimble, et al.
Pediatric Blood & Cancer|April 12, 2018
Epidemiologic and clinical characteristics of nontransfusion-dependent thalassemia in the United StatesElliott Vichinsky, Alan Cohen, Alexis A Thompson, et al.
The Lancet. Haematology|April 10, 2021
Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trialJo Howard, Kenneth I Ataga, Robert C Brown, et al.
American Journal of Hematology|November 10, 2006
Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overloadEllen B Fung, Paul Harmatz, Meredith Milet, et al.
Magnetic Resonance Imaging|January 12, 2010
Assessment of cardiac iron by MRI susceptometry and R2* in patients with thalassemiaZhiyue J Wang, Roland Fischer, Zili Chu, et al.
American Journal of Hematology|June 13, 2013
Pregnancy outcomes in women with thalassemia in North America and the United KingdomAlexis A Thompson, Hae-Young Kim, Sylvia T Singer, et al.
AIDS Research and Human Retroviruses|February 16, 2013
Human T cell lymphotropic virus type 1 infection among U.S. thalassemia patientsWilliam M Switzer, Anupama Shankar, Sean R Trimble, et al.
Haematologica|May 13, 2008
Inflammation and oxidant-stress in beta-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trialPatrick B Walter, Eric A Macklin, John Porter, et al.
American Journal of Hematology|April 28, 2011
Iron chelation adherence to deferoxamine and deferasirox in thalassemiaFelicia Trachtenberg, Elliott Vichinsky, Dru Haines, et al.
Plos One|April 9, 2020
Influence of sickle cell disease on susceptibility to HIV infectionShannon Kelly, Evan S Jacobs, Mars Stone, et al.
Pageof 14

Showing results (91-100 of 132) with videos related to

Sort By:
Pageof 14
Transfusion|July 30, 2013
Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME)Elliott Vichinsky, Lynne Neumayr, Sean Trimble, et al.
Pediatric Blood & Cancer|April 12, 2018
Epidemiologic and clinical characteristics of nontransfusion-dependent thalassemia in the United StatesElliott Vichinsky, Alan Cohen, Alexis A Thompson, et al.
The Lancet. Haematology|April 10, 2021
Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trialJo Howard, Kenneth I Ataga, Robert C Brown, et al.
American Journal of Hematology|November 10, 2006
Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overloadEllen B Fung, Paul Harmatz, Meredith Milet, et al.
Magnetic Resonance Imaging|January 12, 2010
Assessment of cardiac iron by MRI susceptometry and R2* in patients with thalassemiaZhiyue J Wang, Roland Fischer, Zili Chu, et al.
American Journal of Hematology|June 13, 2013
Pregnancy outcomes in women with thalassemia in North America and the United KingdomAlexis A Thompson, Hae-Young Kim, Sylvia T Singer, et al.
AIDS Research and Human Retroviruses|February 16, 2013
Human T cell lymphotropic virus type 1 infection among U.S. thalassemia patientsWilliam M Switzer, Anupama Shankar, Sean R Trimble, et al.
Haematologica|May 13, 2008
Inflammation and oxidant-stress in beta-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trialPatrick B Walter, Eric A Macklin, John Porter, et al.
American Journal of Hematology|April 28, 2011
Iron chelation adherence to deferoxamine and deferasirox in thalassemiaFelicia Trachtenberg, Elliott Vichinsky, Dru Haines, et al.
Plos One|April 9, 2020
Influence of sickle cell disease on susceptibility to HIV infectionShannon Kelly, Evan S Jacobs, Mars Stone, et al.
Pageof 14